SCHEDULE 13D: Nutriband President Serguei Melnik Discloses 9.39% Beneficial Ownership in SEC Filing

Serguei Melnik, President of Nutriband Inc., has filed a Schedule 13D with the SEC, disclosing beneficial ownership of 9.39% of the company's common stock.

Summary

• Serguei Melnik, President of Nutriband Inc., filed a Schedule 13D to report his beneficial ownership in the company.
• As of March 1, 2025, Mr. Melnik beneficially owns an aggregate of 1,071,418 shares of Nutriband Inc. common stock.
• This ownership represents 9.39% of the company's outstanding common stock, which is based on 11,154,171 shares outstanding as of March 1, 2025.
• His holdings include 820,418 shares issued as founder's stock in 2016 during the company's formation.
• Additionally, he holds options to purchase 251,000 shares of common stock, granted under the Issuer's stock option plan between January 21, 2021, and January 23, 2025, with exercise prices ranging from $2.12 to $8.07.
• Mr. Melnik has not yet exercised any of the granted options.
• The purpose of his holdings is for investment, and he may, depending on market conditions, purchase additional shares or sell existing ones.
• He may also engage in discussions with the Board and management regarding the company's business, operations, capital structure, governance, and strategy.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership by a key insider. It does not contain new financial results, strategic shifts, or events that would inherently be interpreted as significantly positive or negative for the company's immediate prospects. It's a routine regulatory update.

Positives

• The President's significant beneficial ownership (9.39%) aligns his interests with those of other shareholders.
• The stated purpose of holding shares for investment indicates a long-term perspective from a key insider.

Risks

• The Reporting Person may, at his discretion, sell all or a portion of his beneficially owned shares or related derivatives, which could exert downward pressure on the stock price.
• Future actions by the Reporting Person, including purchases or sales, are dependent on various factors such as market conditions, the Issuer's performance, and alternative investment opportunities, introducing uncertainty.

Future Outlook

The Reporting Person intends to review his investments in Nutriband Inc. and may, depending on market and other conditions, purchase additional shares or sell all or a portion of his current holdings. He may also engage in discussions with the Issuer's Board and management concerning potential business combinations, strategic alternatives, operations, capital structure, governance, and management.

Management Comments

• "The Reporting Person holds the common stock of the Issuer for investment purposes."
• "The Reporting Person may, from time to time, acquire additional shares of common stock and/or retain and/or sell all or a portion of the shares of common stock held by the Reporting Person in the open market or in privately negotiated transactions."
• "From time to time the Reporting Persons may engage in discussions with the Board and/or members of the Issuer's management team concerning, including, without limitation, potential business combinations and strategic alternatives, the business, operations, capital structure, governance, management, strategy of the Issuer and other matters concerning the Issuer."

Industry Context

Nutriband Inc. operates in the medical device research and development sector. This filing is a standard disclosure of beneficial ownership by a key insider (the President) and does not provide broader industry-specific insights or trends.

Legal Proceedings

• The Reporting Person has not been convicted in a criminal proceeding (excluding traffic violations and similar misdemeanors) during the last five years.
• Neither the Reporting Person nor any controlling persons have been party to a civil proceeding of a judicial or administrative body that resulted in a judgment, decree, or final order enjoining future violations of, or prohibiting or mandating activities subject to, U.S. federal or state securities laws, or finding any violations with respect to such laws, during the last five years.

Related Party Transactions

• 820,418 shares were issued to the Reporting Person (President) as founder's stock in connection with the formation of the Company in 2016.
• The Company issued options to the Reporting Person (President) to purchase an aggregate of 251,000 shares of common stock as compensation pursuant to the Issuer's stock option plan.

Stakeholder Impact

• Shareholders: Provides transparency regarding the significant ownership stake and future intentions of the company's President, which can influence investor confidence and perception of insider alignment.
• Management: Confirms the President's direct financial interest in the company's performance and his potential engagement in strategic discussions.

Next Steps

• The Reporting Person may purchase additional shares of common stock or equity securities of the Issuer.
• The Reporting Person may sell all or a portion of the shares of common stock or related derivatives beneficially owned.
• The Reporting Person may engage in discussions with the Issuer's Board and/or management team regarding various corporate matters.

Key Dates

Recommendation

Keywords

Nutriband Inc., Serguei Melnik, Schedule 13D, beneficial ownership, common stock, stock options, founder's stock, SEC filing, insider ownership, medical device research and development